But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...

FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

The Food and Drug Administration's new AI tool, Elsa, is reportedly generating false studies, raising concerns about the ...

AI is changing how drugs are manufactured, particularly when it comes to getting them approved. Because it is so fast at processing information, the whole appro ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

FDA's Embrace of AI to Speed Up Drug Approvals Leaves Industry Observers Excited, Uneasy 6 minute read June 06, 2025. By. John Russell. Email. Share. Print. Credit: Maksim Šmeljov/Adobe Stock.

Overall, just 1 out of 10 drug candidates that gets through animal testing succeeds all the way through clinical trials and gains regulatory approval. AI is helping close the translational gap.